rdf:type |
|
lifeskim:mentions |
umls-concept:C0024554,
umls-concept:C0031327,
umls-concept:C0040808,
umls-concept:C0042960,
umls-concept:C0178602,
umls-concept:C0728475,
umls-concept:C0851347,
umls-concept:C0905464,
umls-concept:C1512523,
umls-concept:C1549078,
umls-concept:C1997894
|
pubmed:issue |
5
|
pubmed:dateCreated |
2005-11-7
|
pubmed:abstractText |
We conducted a randomized, double-blind, placebo-controlled study to evaluate the pharmacokinetics and pharmacodynamics of landiolol hydrochloride in a dose escalation regimen in healthy male volunteers.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1347-4367
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
337-44
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16272751-Adrenergic beta-Antagonists,
pubmed-meshheading:16272751-Adult,
pubmed-meshheading:16272751-Blood Pressure,
pubmed-meshheading:16272751-Dose-Response Relationship, Drug,
pubmed-meshheading:16272751-Double-Blind Method,
pubmed-meshheading:16272751-Heart Rate,
pubmed-meshheading:16272751-Humans,
pubmed-meshheading:16272751-Male,
pubmed-meshheading:16272751-Morpholines,
pubmed-meshheading:16272751-Urea
|
pubmed:year |
2005
|
pubmed:articleTitle |
Pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra short-acting beta1-selective blocker, in a dose escalation regimen in healthy male volunteers.
|
pubmed:affiliation |
Kyushu Clinical Pharmacology Research Clinic, Fukuoka, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|